Literature DB >> 8531498

Arachidonic acid metabolites and glucocorticoid regulatory mechanism in cultured porcine tracheal smooth muscle cells.

H Tanaka1, K Watanabe, N Tamaru, M Yoshida.   

Abstract

To elucidate the signal transduction system in the production of prostaglandin E2 (PGE2) by porcine tracheal smooth muscle cells in culture (PTSMC), we examined the pattern of arachidonic acid metabolites released from PTSMC and the relationship between bradykinin-stimulated rises in intracellular calcium concentration ([Ca2+]i) and PGE2 production by PTSMC. We next examined the effect of dexamethasone on these parameters. Bradykinin induced a dose-dependent increase in both the rise in [Ca2+]i and PGE2 production by PTSMC. The increase in [Ca2+]i paralleled an increase in PGE2 production. High-performance liquid chromatography (HPLC) revealed that dexamethasone-treated PTSMC were suppressed to release arachidonic acid metabolites such as PGE2 and prostaglandin F2 alpha (PGF2 alpha). Incubation of PTSMC with 10(-6)M dexamethasone for 24 h significantly suppressed both the rise in [Ca2+]i and PGE2 production by PTSMC in response to bradykinin, and also significantly suppressed bradykinin-stimulated release of radioactivity from PTSMC prelabeled with 3H-labeled arachidonic acid (3H-AA). When PTSMC pretreated with dexamethasone were incubated with 170 nM prostaglandin H2 (PGH2) or 20 microM arachidonic acid; PTSMC synthesized less PGE2 than control PTSMC. Results suggest that bradykinin stimulates PTSMC to produce PGE2 via the signal transduction system including Ca2+, and dexamethasone appeared to suppress PGE2 production by reducing the activity of cytosolic phospholipase A2 (cPLA2) and PGE2 synthase. However, we failed to demonstrate the suppression of the activity of cyclooxygenase in PTSMC by dexamethasone. Since the elevation of [Ca2+]i is necessary for the contraction of airway smooth muscles, dexamethasone seems to reduce the contraction of airway smooth muscles by suppressing the rise in [Ca2+]i and the release of arachidonic acid metabolites. Reduced production of arachidonic acid metabolites may also contribute to improvement in the bronchial inflammation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8531498     DOI: 10.1007/bf00172142

Source DB:  PubMed          Journal:  Lung        ISSN: 0341-2040            Impact factor:   2.584


  42 in total

1.  Anaphylactic release of prostaglandins from human lung in vitro.

Authors:  N F Adkinson; H H Newball; S Findlay; K Adams; L M Lichtenstein
Journal:  Am Rev Respir Dis       Date:  1980-06

2.  Arachidonic acid metabolites and endothelial injury: studies with cultures of human endothelial cells.

Authors:  A R Johnson; G Revtyak; W B Campbell
Journal:  Fed Proc       Date:  1985-01

3.  The induction and suppression of prostaglandin H2 synthase (cyclooxygenase) in human monocytes.

Authors:  J Y Fu; J L Masferrer; K Seibert; A Raz; P Needleman
Journal:  J Biol Chem       Date:  1990-10-05       Impact factor: 5.157

4.  Dexamethasone inhibits the antigen-induced contractile activity and release of inflammatory mediators in isolated guinea pig lung tissue.

Authors:  R P Schleimer; B J Undem; S Meeker; M E Bollinger; N F Adkinson; L M Lichtenstein; G K Adams
Journal:  Am Rev Respir Dis       Date:  1987-03

5.  An effect of dexamethasone on adenosine 3',5'-monophosphate content and adenosine 3',5'-monophosphate phosphodiesterase activity of cultured hepatoma cells.

Authors:  V Manganiello; M Vaughan
Journal:  J Clin Invest       Date:  1972-10       Impact factor: 14.808

6.  Simultaneous measurements of cytosolic free calcium level and prostaglandin synthesis reveal a correlation between them in perfused monolayer of cultured rat vascular smooth muscle cells: effects of bradykinin and angiotensin II.

Authors:  K Takeuchi; K Abe; K Maeyama; M Sato; M Yasujima; T Watanabe; K Yoshinaga
Journal:  Tohoku J Exp Med       Date:  1991-11       Impact factor: 1.848

7.  Bradykinin-induced bronchoconstriction in humans. Mode of action.

Authors:  R W Fuller; C M Dixon; F M Cuss; P J Barnes
Journal:  Am Rev Respir Dis       Date:  1987-01

8.  Leukotriene D4 receptor-mediated hydrolysis of phosphoinositide and mobilization of calcium in sheep tracheal smooth muscle cells.

Authors:  S Mong; J Miller; H L Wu; S T Crooke
Journal:  J Pharmacol Exp Ther       Date:  1988-02       Impact factor: 4.030

9.  Mechanisms underlying the inhibitory effect of dibutyryl cyclic AMP in vascular smooth muscle.

Authors:  A Abe; H Karaki
Journal:  Eur J Pharmacol       Date:  1992-02-18       Impact factor: 4.432

10.  Bradykinin stimulates Cl secretion and prostaglandin E2 release by canine tracheal epithelium.

Authors:  G D Leikauf; I F Ueki; J A Nadel; J H Widdicombe
Journal:  Am J Physiol       Date:  1985-01
View more
  5 in total

1.  Mechanisms underlying the relaxation response induced by bradykinin in the epithelium-intact guinea-pig trachea in vitro.

Authors:  Valfredo Schlemper; Rodrigo Medeiros; Juliano Ferreira; Maria M Campos; João B Calixto
Journal:  Br J Pharmacol       Date:  2005-07       Impact factor: 8.739

2.  Cytosolic phospholipase A2alpha mediates Pseudomonas aeruginosa LPS-induced airway constriction of CFTR -/- mice.

Authors:  Yong-Zheng Wu; Mohammad Abolhassani; Mario Ollero; Fariel Dif; Naonori Uozumi; Micheline Lagranderie; Takao Shimizu; Michel Chignard; Lhousseine Touqui
Journal:  Respir Res       Date:  2010-04-29

Review 3.  Glucocorticoids shift arachidonic acid metabolism toward endocannabinoid synthesis: a non-genomic anti-inflammatory switch.

Authors:  Renato Malcher-Lopes; Alier Franco; Jeffrey G Tasker
Journal:  Eur J Pharmacol       Date:  2008-01-31       Impact factor: 4.432

4.  Inhibition of prostaglandin D synthase suppresses muscular necrosis.

Authors:  Ikuko Mohri; Kosuke Aritake; Hidetoshi Taniguchi; Yo Sato; Shinya Kamauchi; Nanae Nagata; Toshihiko Maruyama; Masako Taniike; Yoshihiro Urade
Journal:  Am J Pathol       Date:  2009-04-09       Impact factor: 4.307

5.  Steroids augment relengthening of contracted airway smooth muscle: potential additional mechanism of benefit in asthma.

Authors:  O J Lakser; M L Dowell; F L Hoyte; B Chen; T L Lavoie; C Ferreira; L H Pinto; N O Dulin; P Kogut; J Churchill; R W Mitchell; J Solway
Journal:  Eur Respir J       Date:  2008-09-03       Impact factor: 16.671

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.